SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,415,149 | -40.8% | 61,171 | -44.0% | 0.08% | -31.7% |
| Q2 2023 | $12,519,326 | -60.4% | 109,320 | -52.3% | 0.12% | -63.3% |
| Q1 2023 | $31,582,780 | -6.9% | 229,143 | -12.4% | 0.33% | -11.4% |
| Q4 2022 | $33,910,827 | +8.0% | 261,698 | -7.8% | 0.37% | +0.3% |
| Q3 2022 | $31,388,000 | -6.5% | 283,950 | -36.6% | 0.37% | -4.9% |
| Q2 2022 | $33,588,000 | -13.0% | 448,080 | -9.3% | 0.39% | +10.9% |
| Q1 2022 | $38,591,000 | -22.7% | 493,996 | -10.9% | 0.35% | -11.6% |
| Q4 2021 | $49,917,000 | -14.7% | 554,323 | -12.4% | 0.40% | -14.1% |
| Q3 2021 | $58,510,000 | +22.3% | 632,679 | +2.8% | 0.46% | +31.1% |
| Q2 2021 | $47,855,000 | +182.5% | 615,580 | +169.2% | 0.35% | +185.4% |
| Q1 2018 | $16,940,000 | – | 228,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |